HMI-115 Hair Loss
Positive news to start the new year with Hope Medicine’s HMI-115 Phase 1b results announced on January 14th, 2024. Successful Results for Male Participants Hope Medicine has released positive data from their Phase 1b trial conducted in Australia titled, “An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgenetic Alopecia…
Read More
The long awaited phase 2 trial of Hope Medicine’s HMI-115 in androgenetic alopecia has officially begun. HMI-115 Antibody Starts Phase 2 Trial It has almost been two full years since Hope Medicine issued an exciting press release which announced the company’s approval to conduct a phase 2 clinical trial with the US FDA. Since then,…
Read More